The Prognostic Utility of the Triceps Skinfold Thickness Albumin Index in Colorectal Cancer Patients with Cachexia

To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia. This study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated b...

Full description

Saved in:
Bibliographic Details
Published inNutrition and cancer Vol. 77; no. 2; pp. 265 - 275
Main Authors Liu, Xiao-Yue, Lin, Shi-Qi, Ruan, Guo-Tian, Zheng, Xin, Chen, Yue, Zhang, He-yang, Liu, Tong, Xie, Hai-Lun, Shi, Han-Ping
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 07.02.2025
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia. This study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan-Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out. We included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40-0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA. TA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.
AbstractList To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia. This study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan-Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out. We included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40-0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA. TA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.
PurposeTo develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia.MethodsThis study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan–Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out.ResultsWe included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40–0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA.ConclusionsTA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.
To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia.PURPOSETo develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia.This study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan-Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out.METHODSThis study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan-Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out.We included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40-0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA.RESULTSWe included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40-0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA.TA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.CONCLUSIONSTA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.
To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients with colorectal cancer cachexia. This study was a multi-centre cohort study. The triceps skinfold thickness-albumin index (TA) was calculated by combining the triceps skinfold thickness (TSF) and serum albumin levels. Kaplan–Meier analysis and Cox proportional risk regression models were used to assess the relationship between the TA and all-cause mortality. Internal validation was carried out. We included 1025 patients with colorectal cancer cachexia, 61.2% of whom were male, with a mean age of 58.91 (12.45) years. As the TA increased, overall mortality decreased in female patients (hazard ratio [HR], 0.95) but not in male patients (HR, 0.99). Multivariate Cox analysis showed that patients in the normal TA group had a significantly lower risk of death than those in the low TA group (HR, 0.53, 95% CI, 0.40–0.72). Patients with a normal TA had a lower risk of malnutrition, poor quality of life, and poor short-term prognosis than those with a low TA. TA index enables clinicians to assess the prognosis of patients as early as possible to improve the survival of patients with colorectal cancer cachexia.
Author Liu, Xiao-Yue
Ruan, Guo-Tian
Xie, Hai-Lun
Lin, Shi-Qi
Liu, Tong
Shi, Han-Ping
Zhang, He-yang
Zheng, Xin
Chen, Yue
Author_xml – sequence: 1
  givenname: Xiao-Yue
  surname: Liu
  fullname: Liu, Xiao-Yue
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 2
  givenname: Shi-Qi
  surname: Lin
  fullname: Lin, Shi-Qi
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 3
  givenname: Guo-Tian
  surname: Ruan
  fullname: Ruan, Guo-Tian
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 4
  givenname: Xin
  surname: Zheng
  fullname: Zheng, Xin
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 5
  givenname: Yue
  surname: Chen
  fullname: Chen, Yue
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 6
  givenname: He-yang
  surname: Zhang
  fullname: Zhang, He-yang
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 7
  givenname: Tong
  surname: Liu
  fullname: Liu, Tong
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 8
  givenname: Hai-Lun
  surname: Xie
  fullname: Xie, Hai-Lun
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
– sequence: 9
  givenname: Han-Ping
  surname: Shi
  fullname: Shi, Han-Ping
  organization: Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39420584$$D View this record in MEDLINE/PubMed
BookMark eNqN0ctu3CAUBmBUpUomaR6hFVI23XjKxWC8SzTqJVKkRupkbTH40CGxYQpYybx9sWbSRRdVVyD4zhGc_xyd-OABofeULClR5BOhkguh6JIRVi9ZTSUT5A1aUMFZ1bS0PkGL2VQzOkPnKT0SQhrK1Sk6423NiFD1AsX1FvB9DD99SNkZ_JDd4PIeB4tzuVlHZ2CX8I8n520YerzeOvPkISV8M2ym0Xl863t4wWWzCkOIYLIe8Ep7AxHf6-zA54SfXd6WQ7OFF6ffobdWDwkuj-sFevjyeb36Vt19_3q7urmrDG9EriSoXhoppITaCqUIM2BtswEtFSeN1dwQI4hVwoIwuu37WioJnGvGGisNv0AfD313MfyaIOVudMnAMGgPYUodp1KoRijG_4PSpm0VZ6TQq7_oY5iiLx8pqm7bmjNBi_pwVNNmhL7bRTfquO9eB1-AOAATQ0oR7B9CSTcH3L0G3M0Bd8eAS931oW7OI476OcSh77Lel9nbWMbu5nf8s8VvPbmrMg
Cites_doi 10.1097/JU.0000000000002342
10.20960/nh.03696
10.3390/ijms221910318
10.1186/s12957-021-02253-y
10.18502/ijph.v49i7.3577
10.1016/j.clnu.2017.06.017
10.1002/bjs.7305
10.1002/jcp.26811
10.1017/S0007114521002853
10.1002/jcsm.13156
10.2174/18735592MTEx9NTk2y
10.3322/caac.21660
10.1097/00042560-199611010-00013
10.1038/sj.ejcn.1601412
10.1002/jpen.2321
10.1016/j.clnu.2021.11.026
10.1152/ajpcell.1988.255.3.C368
10.1016/s0261-5614(03)00098-0
10.1097/PN9.0000000000000014
10.1016/j.tranon.2022.101480
10.3322/caac.21492
10.1016/j.ejso.2016.05.029
10.1016/j.jhep.2018.04.015
10.3389/fnut.2021.738550
10.3389/fonc.2021.707705
10.1634/theoncologist.2019-0348
10.1016/j.nut.2009.04.013
10.1038/oncsis.2016.3
10.1017/S0007114521002531
10.1016/s0899-9007(01)00621-9
10.2147/CMAR.S318728
10.1007/s00520-021-06486-1
10.1097/00005373-199010000-00001
10.1016/j.nut.2022.111811
10.1016/j.semcdb.2015.09.001
10.1002/cncr.21013
ContentType Journal Article
Copyright 2024 Taylor & Francis Group, LLC 2024
2024 Taylor & Francis Group, LLC
Copyright_xml – notice: 2024 Taylor & Francis Group, LLC 2024
– notice: 2024 Taylor & Francis Group, LLC
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U7
C1K
7X8
7S9
L.6
DOI 10.1080/01635581.2024.2416250
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE
Toxicology Abstracts
MEDLINE - Academic
AGRICOLA

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1532-7914
EndPage 275
ExternalDocumentID 39420584
10_1080_01635581_2024_2416250
2416250
Genre Research Article
Multicenter Study
Journal Article
GrantInformation_xml – fundername: National Key Research and Development Program
  grantid: 2022YFC2009600
GroupedDBID ---
.7I
.QK
0BK
0R~
123
29N
36B
4.4
5RE
5VS
6PF
AAGZJ
AAHBH
AALUX
AAMIU
AAPUL
AAQRR
AATTQ
AAWTL
ABBKH
ABDBF
ABEIZ
ABJNI
ABLCE
ABLIJ
ABPEM
ABTAI
ABUPF
ABXYU
ABZLS
ACENM
ACGFS
ACGOD
ACKLR
ACPRK
ACTOA
ACVOX
ADBBV
ADCVX
ADOJX
AECIN
AEKEX
AEOZL
AEPSL
AEXWM
AFRAH
AGDLA
AGFJD
AGMYJ
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
ARJSQ
AVBZW
AWYRJ
BLEHA
BMOTO
BMSDO
BOHLJ
CCCUG
CQ1
CS3
DKSSO
EAL
EAP
EBS
ECT
ESTFP
ESX
E~B
E~C
F5P
G-F
GTTXZ
H13
HF~
HZ~
IPNFZ
J.O
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
NA5
O9-
PQQKQ
RIG
RNANH
RVRKI
S-F
STATR
TBQAZ
TDBHL
TERGH
TFL
TFW
TNTFI
TUROJ
UEQFS
UT5
UT9
VAE
~01
~KM
~S~
04C
A8Z
AAGDL
AAYXX
ABWVI
ACIEZ
ACUHS
ADYSH
AFRVT
AMPGV
CITATION
DGFLZ
EBB
EBC
EBD
ECF
EIHBH
EMB
EMK
EMOBN
ENC
EPL
EPT
NZ~
Q~Q
SV3
TUS
.GJ
07V
1PE
53G
AADGC
AAIAR
AAYJJ
ABFIM
ABGNL
ABWXJ
ACKFH
ACWGZ
ADPSL
ADVEQ
AEIQB
AELXL
AETHL
AEXKJ
AFFNX
AFLJA
AFWDB
AGXXK
AIKPT
AJSLH
AOVRU
APIUT
BTKSN
C04
CAG
CGR
COF
COGVJ
CUY
CVF
DMVAR
EBX
ECM
ECV
EIF
EJD
HAMGP
NPM
NUSFT
ROL
UC6
UDS
UV3
V5Y
WQ9
ZGI
ZXP
7U7
C1K
TASJS
7X8
7S9
L.6
ID FETCH-LOGICAL-c375t-6e8d6c6566e4f58802ceff7bea68307fa3c0c50f85fe5ca9dd4686e33a227f6c3
ISSN 0163-5581
1532-7914
IngestDate Tue Aug 05 11:00:45 EDT 2025
Mon Jul 21 09:39:48 EDT 2025
Wed Aug 13 09:21:53 EDT 2025
Wed Feb 19 01:58:22 EST 2025
Tue Jul 01 01:23:13 EDT 2025
Mon Dec 30 04:19:16 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c375t-6e8d6c6566e4f58802ceff7bea68307fa3c0c50f85fe5ca9dd4686e33a227f6c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 39420584
PQID 3149943251
PQPubID 105635
PageCount 11
ParticipantIDs pubmed_primary_39420584
proquest_miscellaneous_3165875823
crossref_primary_10_1080_01635581_2024_2416250
proquest_miscellaneous_3117998320
proquest_journals_3149943251
informaworld_taylorfrancis_310_1080_01635581_2024_2416250
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-02-07
PublicationDateYYYYMMDD 2025-02-07
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-07
  day: 07
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Mahwah
PublicationTitle Nutrition and cancer
PublicationTitleAlternate Nutr Cancer
PublicationYear 2025
Publisher Taylor & Francis
Taylor & Francis Ltd
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
References DeWys WD. (e_1_3_7_5_1) 1982; 42
Smith G (e_1_3_7_30_1) 1994; 10
e_1_3_7_21_1
e_1_3_7_20_1
e_1_3_7_23_1
e_1_3_7_22_1
e_1_3_7_25_1
e_1_3_7_24_1
e_1_3_7_27_1
e_1_3_7_26_1
e_1_3_7_29_1
e_1_3_7_28_1
e_1_3_7_32_1
e_1_3_7_10_1
e_1_3_7_31_1
e_1_3_7_11_1
e_1_3_7_34_1
e_1_3_7_12_1
e_1_3_7_33_1
e_1_3_7_13_1
e_1_3_7_36_1
e_1_3_7_14_1
e_1_3_7_35_1
e_1_3_7_15_1
e_1_3_7_38_1
e_1_3_7_16_1
e_1_3_7_37_1
e_1_3_7_17_1
e_1_3_7_18_1
e_1_3_7_39_1
e_1_3_7_19_1
e_1_3_7_3_1
e_1_3_7_2_1
e_1_3_7_4_1
e_1_3_7_7_1
e_1_3_7_6_1
e_1_3_7_9_1
e_1_3_7_8_1
References_xml – volume: 42
  start-page: 721s
  issue: 2
  year: 1982
  ident: e_1_3_7_5_1
  article-title: Pathophysiology of cancer cachexia: current understanding and areas for future research
  publication-title: Cancer Res
– ident: e_1_3_7_14_1
  doi: 10.1097/JU.0000000000002342
– ident: e_1_3_7_37_1
  doi: 10.20960/nh.03696
– ident: e_1_3_7_29_1
  doi: 10.3390/ijms221910318
– ident: e_1_3_7_27_1
  doi: 10.1186/s12957-021-02253-y
– ident: e_1_3_7_38_1
  doi: 10.18502/ijph.v49i7.3577
– ident: e_1_3_7_7_1
  doi: 10.1016/j.clnu.2017.06.017
– ident: e_1_3_7_28_1
  doi: 10.1002/bjs.7305
– ident: e_1_3_7_36_1
  doi: 10.1002/jcp.26811
– ident: e_1_3_7_16_1
  doi: 10.1017/S0007114521002853
– ident: e_1_3_7_26_1
  doi: 10.1002/jcsm.13156
– ident: e_1_3_7_4_1
  doi: 10.2174/18735592MTEx9NTk2y
– volume: 10
  start-page: 335
  issue: 4
  year: 1994
  ident: e_1_3_7_30_1
  article-title: Albumin catabolic rate and protein-energy depletion
  publication-title: Nutrition
– ident: e_1_3_7_3_1
  doi: 10.3322/caac.21660
– ident: e_1_3_7_22_1
  doi: 10.1097/00042560-199611010-00013
– ident: e_1_3_7_21_1
  doi: 10.1038/sj.ejcn.1601412
– ident: e_1_3_7_12_1
  doi: 10.1002/jpen.2321
– ident: e_1_3_7_39_1
  doi: 10.1016/j.clnu.2021.11.026
– ident: e_1_3_7_33_1
  doi: 10.1152/ajpcell.1988.255.3.C368
– ident: e_1_3_7_20_1
  doi: 10.1016/s0261-5614(03)00098-0
– ident: e_1_3_7_19_1
  doi: 10.1097/PN9.0000000000000014
– ident: e_1_3_7_25_1
  doi: 10.1016/j.tranon.2022.101480
– ident: e_1_3_7_2_1
  doi: 10.3322/caac.21492
– ident: e_1_3_7_13_1
  doi: 10.1016/j.ejso.2016.05.029
– ident: e_1_3_7_34_1
  doi: 10.1016/j.jhep.2018.04.015
– ident: e_1_3_7_9_1
  doi: 10.3389/fnut.2021.738550
– ident: e_1_3_7_24_1
  doi: 10.3389/fonc.2021.707705
– ident: e_1_3_7_23_1
  doi: 10.1634/theoncologist.2019-0348
– ident: e_1_3_7_8_1
  doi: 10.1016/j.nut.2009.04.013
– ident: e_1_3_7_35_1
  doi: 10.1038/oncsis.2016.3
– ident: e_1_3_7_17_1
  doi: 10.1017/S0007114521002531
– ident: e_1_3_7_31_1
  doi: 10.1016/s0899-9007(01)00621-9
– ident: e_1_3_7_10_1
  doi: 10.2147/CMAR.S318728
– ident: e_1_3_7_11_1
  doi: 10.1007/s00520-021-06486-1
– ident: e_1_3_7_32_1
  doi: 10.1097/00005373-199010000-00001
– ident: e_1_3_7_18_1
  doi: 10.1016/j.nut.2022.111811
– ident: e_1_3_7_6_1
  doi: 10.1016/j.semcdb.2015.09.001
– ident: e_1_3_7_15_1
  doi: 10.1002/cncr.21013
SSID ssj0007138
Score 2.444122
Snippet To develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of patients...
PurposeTo develop a simple and convenient inflammation-nutrition-adiposity biomarker to complement the TNM staging system, further assess the prognosis of...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 265
SubjectTerms Adipose tissue
Aged
Albumin
Biomarkers
Cachexia
Cachexia - etiology
Cachexia - mortality
Cancer
Cohort Studies
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Colorectal Neoplasms - complications
Colorectal Neoplasms - mortality
death
Female
females
hazard ratio
Health risks
Humans
Kaplan-Meier Estimate
Male
Males
Malnutrition
Medical prognosis
Middle Aged
Mortality
nutrition
Nutritional Status
Prognosis
Proportional Hazards Models
Quality of Life
Regression analysis
Regression models
risk
Serum albumin
Serum Albumin - analysis
Skinfold Thickness
Thickness
Title The Prognostic Utility of the Triceps Skinfold Thickness Albumin Index in Colorectal Cancer Patients with Cachexia
URI https://www.tandfonline.com/doi/abs/10.1080/01635581.2024.2416250
https://www.ncbi.nlm.nih.gov/pubmed/39420584
https://www.proquest.com/docview/3149943251
https://www.proquest.com/docview/3117998320
https://www.proquest.com/docview/3165875823
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66C-KL6HobXSWC-LJ0aJM0bR_3Ni6yOyp0YPSltGnKFJfpMLaw-Os9p0kvi6uuvgylbeb2fT235Hwh5C3QIg9k4DpBwX1HZNxzwsjLHK5Z6KlUgYvHgv7FXJ4txIelvxzNmGJ3SZ1N1Y8b-0r-B1U4B7hil-w_INu_KZyAY8AXXgFheL01xp-2Fa6VQ93VRV1e2hUWGE7GqBe0-X6A-2sVFS6ZWZXqW2va2sJ8ifXAXF-Zxj_I28H2YSkBebBF7f5y6H47Rt3nqzIdx7LzTsjf9Ma1w_r1PWWD4C3LtHK-NHo4bcqtq9L5XPZzPY0pwr5vKicesfXrShtDtLTq4LY4wdpmb7OLbW9PGSpiirHBDYIRsdjBZsravjh_bEfNBhLWJdtrv1h7uzzSw6ApxGSfiSlEJJDSuYN766b05x-T2eL8PIlPl_FdsssgrQC7uHt4dHI06303pOyhUdg1X7vr-UI19ps-5lo0c03r9vcZSxu5xA_JA5ty0EPDn0fkjl7vkclJqWv6jlpd2Evao7lH7l3YBRePyRYoRgeKUUsxWhUUKEYtxWhHMdpTjFqK0ZZiFA4GilFDMdpRjCLFaEexJ2QxO42Pzxy7TYejeODXjtRhLhXmBVoUPvgDpnRRBJlOZQgepEi5cpXvFqFfaF-lUZ4LGUrNecpYUEjFn5KddbXWzwnlTPvcDzQkFa6Q2s2EFCpUWsgs9VyRTci0-7uTjVFjSbxO5NbikyA-icVnQqIxKEndlsEKs2dNwv8ydr9DMLEPPQ4RUSQ4ZAUT8qa_DCYZ59nSta4avAdlFsFVun-6B0J_yNUZn5Bnhh39L-KRYC4kBi9uMfoluT88d_tkp942-hWEyXX22nL7Jzdst1w
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Prognostic+Utility+of+the+Triceps+Skinfold+Thickness+Albumin+Index+in+Colorectal+Cancer+Patients+with+Cachexia&rft.jtitle=Nutrition+and+cancer&rft.au=Liu%2C+Xiao-Yue&rft.au=Lin%2C+Shi-Qi&rft.au=Ruan%2C+Guo-Tian&rft.au=Zheng%2C+Xin&rft.date=2025-02-07&rft.issn=1532-7914&rft.volume=77&rft.issue=2+p.265-275&rft.spage=265&rft.epage=275&rft_id=info:doi/10.1080%2F01635581.2024.2416250&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-5581&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-5581&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-5581&client=summon